Previous studies on mDCs in RA were based on CD33/CD14 expression, describing a larger mDC population than the recently defined CD1c+ mDCs [19], since CD33 is not only expressed on CD1c+ mDCs but also on CD16+ and BDCA-3+ DC subpopulations [11]. The gene discussed is CD33; the disease is rheumatoid arthritis.